Genus PLC
16 March 2001
FOR IMMEDIATE RELEASE 16 March 2001
GENUS PLC
ADDITIONAL INVESTMENT IN GENSEL BIOTECHNOLOGIES LTD
Genus PLC, the AIM listed agriculture and technology company announces that it
is to exercise some of its outstanding warrants in Gensel Biotechnologies
Ltd., by purchasing 429,082 shares in Gensel at C$0.35 per share for a total
investment of C$150,178.70.
Gensel, based in Canada, is an agricultural biotechnologies company focusing
on technologies to improve productivity and value-added traits in livestock.
Its first platform technology is sperm sexing that will allow producers to
pre-select the gender of offspring prior to conception resulting in
significant productivity gains for breeders an producers.
Contact:
Richard Wood Genus plc 01270 536501
Charles Ryland Buchanan Communications 020 7466 5000